Address
Email address
Phone number
https://elitekliinik.eeElite erakliinikElite erakliinik Tartus Sangla 63. Viljatusravi ja günekoloogid, 3D-4D ultraheli, endokrinoloog, nahaarstid, kõrva-nina-kurguarstid, onkoloogid jpm. erialad
Name
Fabula Invest OÜ
Registry code
12349446
VAT number
EE101606099
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.09.2012 (12)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
68201 - Rental and operating of own or leased real estate
18 779 €
-45 791 €
-244%
-
38 108 €
0
Submitted
No tax arrears
-120%
-5%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| OÜ FERTIILSUSE KESKUS 10240426 | 100% - 2 500.00 EUR | - | - | |
| Andrei Sõritsa 25.11.1961 (62) | - | Board member | Direct ownership | |
| Deniss Sõritsa 16.11.1982 (41) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member | |
| Zenith Family Office OÜ 12097803 | - | - | - | Founder |
| 2019 29.06.2020 | 2020 30.06.2021 | 2021 28.06.2022 | 2022 29.06.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 109 172 € | 40 885 € | 18 285 € | 20 728 € | 18 779 € |
| Net profit (loss) for the period | 17 663 € | -50 458 € | -46 209 € | -51 376 € | -45 791 € |
| Profit Margin | 16% | -123% | -253% | -248% | -244% |
| Current Assets | 12 264 € | 19 971 € | 9 217 € | 22 517 € | 4 377 € |
| Fixed Assets | 1 084 209 € | 1 042 563 € | 970 246 € | 940 950 € | 905 772 € |
| Total Assets | 1 096 473 € | 1 062 534 € | 979 463 € | 963 467 € | 910 149 € |
| Current Liabilities | 426 775 € | 413 294 € | 43 461 € | 51 440 € | 57 455 € |
| Non Current Liabilities | 637 756 € | 567 756 € | 900 727 € | 828 128 € | 814 586 € |
| Total Liabilities | 1 064 531 € | 981 050 € | 944 188 € | 879 568 € | 872 041 € |
| Share Capital | - | - | - | - | - |
| Equity | 31 942 € | 81 484 € | 35 275 € | 83 899 € | 38 108 € |
| Employees | 0 | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 6 078.71 € | 241.64 € | - | - |
| 2023 Q4 | 5 092.61 € | 1 208.66 € | - | - |
| 2023 Q3 | 3 877.21 € | 400.26 € | - | - |
| 2023 Q2 | 21 141.15 € | 3 600.02 € | 374.74 € | - |
| 2023 Q1 | 5 791.79 € | 1 961.31 € | 562.11 € | - |
| 2022 Q4 | 5 335.78 € | 3 271.82 € | 562.11 € | - |
| 2022 Q3 | 4 237.94 € | 1 009.41 € | 562.11 € | - |
| 2022 Q2 | 5 264.72 € | 1 000.5 € | 562.11 € | - |
| 2022 Q1 | 5 644.47 € | 2 008.56 € | 562.11 € | - |
| 2021 Q4 | 4 584.39 € | 2 006.99 € | 562.11 € | - |
| 2021 Q3 | 50 869.55 € | 10 642.06 € | 562.11 € | - |
| 2021 Q2 | 4 357.02 € | 1 307.92 € | 562.11 € | - |
| 2021 Q1 | 4 470.23 € | 2 815.94 € | 1 119.97 € | - |
| 2020 Q4 | 6 111.86 € | 3 760.48 € | 1 398.9 € | - |
| 2020 Q3 | 3 618.82 € | 2 499.37 € | 1 398.9 € | - |
| 2020 Q2 | 11 765.45 € | 3 997.45 € | 1 398.9 € | - |
| 2020 Q1 | 30 274.41 € | 7 983.11 € | 1 398.9 € | - |
